Table 3. Comorbid conditions among study cohort at JMC, April-September, 2019.
| Variables | Overall(N = 130) | Asthma (N = 59) | COPD(N = 71) | p -value | |
|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | |||
| Common co-morbidity (n = 61) | yes | 61(46.92) | 20(33.90) | 41(57.75) | 0.007 |
| Heart failure(IHD) | yes | 29(22.31) | 6(10.17) | 23(32.39) | 0.002 |
| Hypertensions | yes | 17(13.08) | 6(10.17) | 11(15.49) | 0.370 |
| Diabetes mellitus | yes | 4(3.08) | 1(1.69) | 3(4.23) | 0.406 |
| Cardiac arrhythmia | yes | 7(5.38) | 1(1.69) | 6 (8.45) | 0.089 |
| Depression | yes | 1(0.77) | 0(0) | 1(1.41) | 0.360 |
| Pulmonary HTN | yes | 39(30.00) | 5(8.47) | 34(47.89) | 0.000 |
| Renal failure | yes | 8(6.15) | 0(0) | 8(11.27) | 0.008 |
| Cancer | yes | 4(3.08) | 2(3.39) | 2(2.82) | 0.851 |
| DVT | yes | 2(1.54) | 1(1.69) | 1(1.41) | 0.895 |
| Pneumonia(SCAP) | yes | 62(47.69) | 32(54.24) | 30(42.25) | 0.173 |
SCAP: severe community acquired pneumonia, IHD: ischemic heart disease, DVT: deep vein thrombosis, HTN: hypertension